VVOS

VVOS

USD

Vivos Therapeutics Inc. Common Stock

$2.630-0.010 (-0.379%)

Precio en Tiempo Real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de Precios

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.640

Máximo

$2.660

Mínimo

$2.554

Volumen

0.00M

Fundamentos de la Empresa

Capitalización de Mercado

16.0M

Industria

Dispositivos médicos

País

United States

Estadísticas de Negociación

Volumen Promedio

0.12M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.91Actual $2.630Máximo $6.28

Noticias Relacionadas

GlobeNewswire

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this

Ver más
Vivos Therapeutics Signs Definitive Agreement to  Acquire Largest Sleep Center Operator in Nevada
Analyst Upgrades

Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2

Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics with a Buy and lowers the price target from $6.6 to $6.2.

Ver más
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2
GlobeNewswire

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31,

Ver más
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
GlobeNewswire

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and

Ver más
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.